CEO of Phibro Animal Health (NASDAQ: PAHC) sells 486 shares for taxes

Rhea-AI Filing Summary

Daniel M Bendheim, President and CEO of Phibro Animal Health, reported the sale of 486 shares of Class A Common Stock at $36.599 per share on 2026-08-04. The disclosure states that these shares were sold in a broker-assisted cashless transaction to satisfy tax withholding upon the receipt of shares from vesting of restricted stock units, leaving him with 3,478 shares held directly afterward.

Insider Trade Summary

Net Seller: 486 shares

Net Sell 1 txn

Insider Bendheim Daniel M

Role President and CEO

Type	Security	Shares	Price	Value
Other	Class A Common Stock F1	486	$36.599	$18K

Holdings After Transaction: Class A Common Stock — 3,478 shares (Direct)

Footnotes (1)

1. F1. Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.

Key Figures

Shares sold: 486 shares Sale price: $36.599 per share Shares owned after transaction: 3,478 shares +1 more

4 metrics

Shares sold 486 shares Class A Common Stock sold on 2026-08-04 to cover tax withholding

Sale price $36.599 per share Price for the 486 Class A Common shares sold

Shares owned after transaction 3,478 shares Direct holdings of Daniel M Bendheim after the sale

Transaction date 2026-08-04 Date of broker-assisted cashless sale for tax withholding

Key Terms

broker assisted cashless exercise program, tax withholding obligations, restricted stock units, vesting and settlement

4 terms

broker assisted cashless exercise program financial

"Represents shares sold in a broker assisted cashless exercise program to satis"

tax withholding obligations financial

"sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon"

restricted stock units financial

"settlement of restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vesting and settlement financial

"upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/06/2026 - 08:10 PM Accepted by SEC EDGAR 08/06/2026 - 08:10 PM Learn about SEC filing dates

FAQ

What insider transaction did Phibro Animal Health (PAHC) report for its CEO?

Phibro Animal Health reported that CEO Daniel M Bendheim sold 486 Class A Common shares. The shares were sold in a broker-assisted cashless transaction to cover tax obligations arising from the vesting and settlement of restricted stock units, not a discretionary open-market sale.

How many PAHC shares did Daniel M Bendheim sell, and at what price?

Daniel M Bendheim sold 486 Phibro Animal Health Class A Common shares at $36.599 per share. This sale was part of a cashless program designed to cover tax withholding obligations tied to the vesting of restricted stock units he received.

Why were Daniel M Bendheim's Phibro Animal Health (PAHC) shares sold?

The 486 shares were sold to satisfy tax withholding obligations connected to vesting restricted stock units. A broker-assisted cashless exercise program handled the sale when Bendheim received Class A Common Stock upon vesting and settlement of those units.

How many Phibro Animal Health (PAHC) shares does the CEO own after this transaction?

After the reported sale, Daniel M Bendheim directly owns 3,478 shares of Phibro Animal Health Class A Common Stock. This figure reflects his direct holdings immediately following the broker-assisted sale used to cover tax obligations on vested restricted stock units.

Was Daniel M Bendheim’s PAHC share sale made under a Rule 10b5-1 trading plan?

The report indicates the Rule 10b5-1 checkbox was not marked for this transaction. Instead, the sale was described as a broker-assisted cashless exercise solely to satisfy tax withholding arising from the vesting and settlement of restricted stock units.

What type of security was involved in Daniel M Bendheim’s PAHC transaction?

The transaction involved Class A Common Stock of Phibro Animal Health. These shares were received upon vesting and settlement of restricted stock units, and a portion—486 shares—was immediately sold to cover associated tax withholding obligations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bendheim Daniel M

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NEW JERSEY 07666

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/04/2026		J		486(1)	D	$36.599	3,478	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.

	/s/ Judith Weinstein, as Attorney-in-Fact for Daniel Bendheim	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)